Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 778

1.

A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation.

Hill JM, Kornblith AB, Jones D, Freeman A, Holland JF, Glicksman AS, Boyett JM, Lenherr B, Brecher ML, Dubowy R, Kung F, Maurer H, Holland JC.

Cancer. 1998 Jan 1;82(1):208-18.

PMID:
9428499
2.

Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.

Spiegler BJ, Kennedy K, Maze R, Greenberg ML, Weitzman S, Hitzler JK, Nathan PC.

J Clin Oncol. 2006 Aug 20;24(24):3858-64. Erratum in: J Clin Oncol. 2006 Nov 10;24(32):5181.

PMID:
16921038
3.

Intermediate-dose methotrexate versus cranial irradiation in childhood acute lymphoblastic leukemia: a ten-year follow-up.

Freeman AI, Boyett JM, Glicksman AS, Brecher ML, Leventhal BG, Sinks LF, Holland JF.

Med Pediatr Oncol. 1997 Feb;28(2):98-107.

PMID:
8986145
4.

Improvement in CNS protective treatment in non-high-risk childhood acute lymphoblastic leukemia: report from the Japanese Children's Cancer and Leukemia Study Group.

Tsurusawa M, Katano N, Yamamoto Y, Hirota T, Koizumi S, Watanabe A, Takeda T, Hatae Y, Yatabe M, Mimaya J, Gushiken T, Nishi K, Anami K, Kikuta A, Kanegane H, Asami K, Nishikawa K, Sekine I, Kawano Y, Iwai A, Furuyama T, Ijichi O, Miyake M, Mugishima H, Fujimoto T, et al.

Med Pediatr Oncol. 1999 Apr;32(4):259-6.

PMID:
10102019
5.

Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.

Schrappe M, Reiter A, Henze G, Niemeyer C, Bode U, Kühl J, Gadner H, Havers W, Plüss H, Kornhuber B, Zintl F, Ritter J, Urban C, Niethammer D, Riehm H.

Klin Padiatr. 1998 Jul-Aug;210(4):192-9.

PMID:
9743952
6.
7.
8.

Cerebral glucose metabolism in survivors of childhood acute lymphoblastic leukemia.

Kähkönen M, Metsähonkala L, Minn H, Utriainen T, Korhonen T, Norvasuo-Heilä MK, Harila-Saari A, Aärimaa T, Suhonen-Polvi H, Ruotsalainen U, Solin O, Salmi TT.

Cancer. 2000 Feb 1;88(3):693-700.

PMID:
10649265
9.

Obesity in survivors of childhood acute lymphoblastic leukemia and lymphoma.

Razzouk BI, Rose SR, Hongeng S, Wallace D, Smeltzer MP, Zacher M, Pui CH, Hudson MM.

J Clin Oncol. 2007 Apr 1;25(10):1183-9.

PMID:
17401007
10.

[Late sequelae of CNS recurrence of acute lymphoblastic leukemia in childhood].

Steinberg S, Hartmann R, Wisniewski S, Berger K, Beck JD, Henze G.

Klin Padiatr. 1998 Jul-Aug;210(4):200-6. German.

PMID:
9743953
11.

Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia.

Iuvone L, Mariotti P, Colosimo C, Guzzetta F, Ruggiero A, Riccardi R.

Cancer. 2002 Dec 15;95(12):2562-70.

12.

Intellectual, neuropsychological, and academic functioning in long-term survivors of leukemia.

Raymond-Speden E, Tripp G, Lawrence B, Holdaway D.

J Pediatr Psychol. 2000 Mar;25(2):59-68.

13.

Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01.

Waber DP, Turek J, Catania L, Stevenson K, Robaey P, Romero I, Adams H, Alyman C, Jandet-Brunet C, Neuberg DS, Sallan SE, Silverman LB.

J Clin Oncol. 2007 Nov 1;25(31):4914-21. Erratum in: J Clin Oncol. 2008 Feb 1;26(4):694. Dosage error in published abstract; MEDLINE/PubMed abstract corrected; Dosage error in article text.

PMID:
17971588
14.

Cognitive functioning in long-term survivors of childhood leukemia: a prospective analysis.

Rubenstein CL, Varni JW, Katz ER.

J Dev Behav Pediatr. 1990 Dec;11(6):301-5.

PMID:
2289962
15.

High-dose methotrexate in childhood all.

Moe PJ, Holen A.

Pediatr Hematol Oncol. 2000 Dec;17(8):615-22. Review.

PMID:
11127393
16.

Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.

Sancho JM, Ribera JM, Oriol A, Hernandez-Rivas JM, Rivas C, Bethencourt C, Parody R, Deben G, Bello JL, Feliu E; Programa para el Estudio y Tratamiento de Hemopatias Malignas Group..

Cancer. 2006 Jun 15;106(12):2540-6.

17.

P300 abnormalities in long-time survivors of acute lymphoblastic leukemia in childhood--side effects of CNS prophylaxis?

Uberall MA, Haupt K, Meier W, Hertzberg H, Beck JD, Wenzel D.

Neuropediatrics. 1996 Jun;27(3):130-5.

PMID:
8837072
18.

CNS prophylaxis of childhood leukemia: what are the long-term neurological, neuropsychological, and behavioral effects?

Stehbens JA, Kaleita TA, Noll RB, MacLean WE Jr, O'Brien RT, Waskerwitz MJ, Hammond GD.

Neuropsychol Rev. 1991 Jun;2(2):147-77. Review.

PMID:
1844707
19.

Methotrexate infusions as central nervous system prophylaxis in children with acute lymphocytic leukemia: the Norwegian experience.

Moe PJ, Holen A, Nygaard R, Glomstein A, Madsen B, Hellebostad M, Stokland T, Wefring KW, Steen-Johnsen J, Nielsen B, Hapnes C, Børsting S.

Pediatr Hematol Oncol. 2003 Apr-May;20(3):187-200.

PMID:
12637215
20.

Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group report.

Kaleita TA, Reaman GH, MacLean WE, Sather HN, Whitt JK.

Cancer. 1999 Apr 15;85(8):1859-65.

PMID:
10223582
Items per page

Supplemental Content

Support Center